Literature DB >> 8977526

Roles of JAK kinases in human GM-CSF receptor signal transduction.

S Watanabe1, T Itoh, K Arai.   

Abstract

The receptors for human interleukin-3 (IL-3) and human granulocyte-macrophage colony-stimulating factor (GM-CSF), hIL-3R, hGM-CSFR, respectively, consists of two subunits, alpha and beta, both of which are members of the cytokine receptor superfamily. Phosphorylation of tyrosine residues in the hGMR beta subunit and several cellular proteins is observed after hGM-CSF stimulation. We analyzed the role of tyrosine residues in the hGMR beta subunit and the nature of tyrosine kinase, JAK2, in hGMR signal transduction using several hGMR beta subunit mutants. In addition to the box1 region, a membrane distal region (a.a. 544-589) of the hGMR beta was required for c-fos activation. Only one tyrosine residue (Tyr577) existed within the region 544 to 589, and substitution of Tyr577 to phenylalanine in GMR beta 589 resulted in loss of c-fos activation. In contrast, the same substitution in a wild type receptor did not affect GM-CSF induced activities such as c-fos messenger RNA (mRNA) induction and proliferation, but the substitution abolished Shc phosphorylation. These results suggest that the activation of Shc is not essential for c-fos activation and several tyrosine residues cooperate for c-fos activation. It is well documented that IL-3 or GM-CSF activate JAK2 in BA/F3 cells. The role of JAK2 in IL-3/GM-CSF functions, however, is largely unknown. We examined the role of JAK2 in GM-CSF induced signaling pathways. Dominant negative JAK2 (delta JAK2) lacking the C-terminus kinase domain suppressed IL-3/GM-CSF induced c-fos activation and c-myc activation and proliferation, suggesting that JAK2 was involved in both signaling pathways. Protein tyrosine phosphatase SHP-2 (also called PTP 1D) and Shc were phosphorylated by IL-3/GM-CSF in BA/F3 cells; however, these phosphorylation events were inhibited by the expression of delta JAK2. Taken together, these results indicate the JAK2 is a primary kinase regulating all the known activities of GM-CSF. JAK2 mediates GM-CSF induced c-fos activation through receptor phosphorylation and Shc/PTP 1D activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977526     DOI: 10.1016/s0091-6749(96)70065-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

Authors:  Liang Li; Hardik Modi; Tinisha McDonald; John Rossi; Jiing-Kuan Yee; Ravi Bhatia
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

Review 2.  Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis.

Authors:  Dae-Seog Lim; Yong-Soo Bae
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

Review 3.  Structural and functional hot spots in cytokine receptors.

Authors:  C J Bagley; J M Woodcock; M A Guthridge; F C Stomski; A F Lopez
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

4.  Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.

Authors:  Shao-Yin Chen; Jean Lu; Yin-Chu Shih; Ching-Hwa Tsai
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils.

Authors:  Makiko Yashiro Furuya; Tomoyuki Asano; Yuya Sumichika; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Eiji Suzuki; Hideko Kozuru; Hiroshi Yatsuhashi; Tomohiro Koga; Hiromasa Ohira; Hideharu Sekine; Atsushi Kawakami; Kiyoshi Migita
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

6.  Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma.

Authors:  Magnus Nilsson; Magdalena Rhedin; Ramon Hendrickx; Susanne Berglund; Antonio Piras; Parmis Blomgran; Anders Cavallin; Mia Collins; Göran Dahl; Bilel Dekkak; Therese Ericsson; Niklas Hagberg; Ann Aurell Holmberg; Agnes Leffler; Anders J Lundqvist; Thomais Markou; James Pinkerton; Lars Rönnblom; Stacey Siu; Vanessa Taylor; Tiiu Wennberg; Dimitrios Zervas; Arian D J Laurence; Suman Mitra; Maria G Belvisi; Mark Birrell; Annika Borde
Journal:  Drug Des Devel Ther       Date:  2022-08-31       Impact factor: 4.319

7.  CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.

Authors:  Mojib Javadi; Terri D Richmond; Kai Huang; Dwayne L Barber
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

8.  JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells.

Authors:  Yuya Fujita; Naoki Matsuoka; Jumpei Temmoku; Makiko Furuya-Yashiro; Tomoyuki Asano; Shuzo Sato; Haruki Matsumoto; Hiroshi Watanabe; Hideko Kozuru; Hiroshi Yatsuhashi; Atsushi Kawakami; Kiyoshi Migita
Journal:  BMC Immunol       Date:  2020-06-15       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.